Predict your next investment

Angel Investor (Individual)
chipwilson.com

See what CB Insights has to offer

Investments

2

Portfolio Exits

1

About Chip Wilson

Chip Wilson is an entrepreneur, philanthropist, and the founder of Westbeach Snowboard and lululemon athletica.

Chip Wilson Headquarter Location

California,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Chip Wilson News

SOLVE FSHD Supports the FSHD Canada Foundation in Funding of US$1.2M in Multidisciplinary Biomarker Grants

May 24, 2022

SOLVE FSHD Supports the FSHD Canada Foundation in Funding of US$1.2M in Multidisciplinary Biomarker Grants VANCOUVER, British Columbia, May 24, 2022 (GLOBE NEWSWIRE) — SOLVE FSHD , the venture-philanthropy organization founded by entrepreneur Chip Wilson, announces its financial support to the FSHD Canada Foundation’s strategic investment of US$1.2M in biomarker grant funding to facilitate biomarker research in facioscapulohumeral muscular dystrophy (FSHD). The FSHD Canada Foundation acknowledges the generous support of SOLVE FSHD towards funding these grants. The biomarker grants have been awarded to the following projects: Circulating biomarkers of disease activity in FSHD: Skeletal muscle exosomes (Professor Enzo Ricci and Dr. Giorgio Tasca, Catholic University of the Sacred Heart, Rome, Italy); IMPROVE FSHD: Artificial intelligence analysis to validate new serum biomarkers and therapeutic target for FSHD and UNDERSTAND FSHD2: An 18-month prospective natural history study to gain insight FSHD2 pathophysiology and disease progression (Dr. Sabrina Sacconi, Nice University Hospital Center); and Investigation of circulating biomarkers in FSHD (Dr. Yi-Wen Chen, Children’s National Medical Center, Washington, DC). These biomarker grant projects were prioritized by SOLVE FSHD based on their proposed potential to impact clinical trial outcomes and accelerate timelines for the development of FSHD therapeutics. Biological markers are either molecules that circulate in the blood (proteins, microRNA, metabolites) or structural features that can be imaged by MRI or ultrasound. Identifying disease-specific biomarkers are critically important because they can confirm an FSHD-related change, can reliably track disease progression and can be an early predictor of the effects of new therapies, resulting in more efficient and shorter clinical trials. “For diseases such as FSHD, there is a tremendous challenge for transforming scientific discoveries into new drug treatments due to the slow-progressing nature of the disease. The goal is to identify a biomarker that changes early and predicts disease progression,” says Dr. Eva Chin, SOLVE FSHD Executive Director. “Funding the development of appropriate biomarkers will help to accelerate the development of new therapies by reducing the duration of clinical trials, potentially reducing the overall cost of developing innovative treatments, and ultimately the discovery of a cure for FSHD.” Facioscapulohumeral muscular dystrophy (FSHD) is a type of muscular dystrophy in which there is progressive muscle degeneration and muscle weakness that leads to an inability to lift objects, groom oneself and walk. About SOLVE FSHD SOLVE FSHD is funding innovative biotech and biopharma research and development activities that accelerate novel treatments of Facioscapulohumeral muscular dystrophy (FSHD) treatment. It is fully funded and created by Canadian entrepreneur and philanthropist Chip Wilson. The founder of yoga-inspired athletic apparel company Lululemon Athletica inc. has been living with FSHD for the last three decades of his life. He has committed $100 million of his own money to create SOLVE FSHD and kick-start funding into projects that fit the organization’s mission: accelerate research into new therapies and find a cure for the disorder by 2027. Future announcements for grant funding will be issued on SOLVE FSHD’s website – https://solvefshd.com. For early-stage companies, contact SOLVE FSHD at [email protected] . If you have FSHD and want to find out about clinical trials or be included in the FSHD registry, please visit SOLVE FSHD’s website – https://solvefshd.com . For more information on the FSHD Canada Foundation, please visit – https://fshd.ca. For media inquiries or to request a media interview, please contact: Kamran Shaikh, Account Director

Chip Wilson Investments

2 Investments

Chip Wilson has made 2 investments. Their latest investment was in ANTA Sports Products as part of their PIPE on June 6, 2019.

CBI Logo

Chip Wilson Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

6/26/2019

PIPE

ANTA Sports Products

$100M

Yes

3

4/11/2012

Growth Equity

Subscribe to see more

$99M

Subscribe to see more

0

Date

6/26/2019

4/11/2012

Round

PIPE

Growth Equity

Company

ANTA Sports Products

Subscribe to see more

Amount

$100M

$99M

New?

Yes

Subscribe to see more

Co-Investors

Sources

3

0

Chip Wilson Portfolio Exits

1 Portfolio Exit

Chip Wilson has 1 portfolio exit. Their latest portfolio exit was DAVIDsTEA on June 05, 2015.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

6/5/2015

IPO

$99M

Public

1

Date

6/5/2015

Exit

IPO

Companies

Valuation

$99M

Acquirer

Public

Sources

1

Chip Wilson Acquisitions

1 Acquisition

Chip Wilson acquired 1 company. Their latest acquisition was Amer Sports on April 02, 2019.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

4/2/2019

$99M

Take Private

13

Date

4/2/2019

Investment Stage

Companies

Valuation

$99M

Total Funding

Note

Take Private

Sources

13

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.